Ponatinib (Iclusig)
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Ponatinib (Iclusig), covering 2013-03-15 to 2026-03-05. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia [Phase 2]